Skip to main content
. 2012 Oct 31;3:e201210005. doi: 10.5936/csbj.201210005

Table 2.

Examples of addressing enzyme inhibition

Enzyme Inhibitor Ki (µM) Performance Source
homoserine dehydrogenase (ThrA) in E. coli CRS-BuOH 31 [51]
wild-type threonine n/a produced 50 mg/L 1-propanol, 30 mg/L 1-butanol
ThrAfbrBC n/a produced >150 mg/L 1-propanol, 100 mg/L 1-butanol
DHAP synthase (AroG) in E. coli K12 ∆tyrR [52, 56]
wild-type L-phenylalanine n/a produced 6 ± 1 mg/L L-tyrosine
D146N n/a produced 71 ± 9 mg/L L-tyrosine
chorismate mutase / prephenate dehydrogenase (TyrA) in E. coli K12 ∆tyrR [52, 57]
wild-type L-tyrosine n/a produced 6 ± 1 mg/L L-tyrosine
M53I,
A354V
n/a produced 86 ± 9 mg/L L-tyrosine
citrate synthase in ethanologenic E. coli KO11 [53, 58]
E. coli gltA NADH 2.8 produced 28 g/L ethanol
B. subtilis citZ n/a produced 42 g/L ethanol
dihydrolipoamide dehydrogenase (LPD) subunit of PDH in E. coli W3110 [54, 55]
wild-type NADH 1.00 produced 7.3 mM ethanol
G354K 10.0 produced 125.8 mM ethanol

n/a – not available